The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses

dc.contributor.authorPérez Ruiz, Alexander
dc.contributor.authorJulià Sapé, Margarida
dc.contributor.authorMercadal, Guillem
dc.contributor.authorOlier, Iván
dc.contributor.authorMajós Torró, Carlos
dc.contributor.authorArús, Carles
dc.date.accessioned2018-12-07T11:49:26Z
dc.date.available2018-12-07T11:49:26Z
dc.date.issued2010-11-29
dc.date.updated2018-07-24T13:02:45Z
dc.description.abstractBackground: Proton Magnetic Resonance (MR) Spectroscopy (MRS) is a widely available technique for those clinical centres equipped with MR scanners. Unlike the rest of MR-based techniques, MRS yields not images but spectra of metabolites in the tissues. In pathological situations, the MRS profile changes and this has been particularly described for brain tumours. However, radiologists are frequently not familiar to the interpretation of MRS data and for this reason, the usefulness of decision-support systems (DSS) in MRS data analysis has been explored. Results: This work presents the INTERPRET DSS version 3.0, analysing the improvements made from its first release in 2002. Version 3.0 is aimed to be a program that 1(st), can be easily used with any new case from any MR scanner manufacturer and 2(nd), improves the initial analysis capabilities of the first version. The main improvements are an embedded database, user accounts, more diagnostic discrimination capabilities and the possibility to analyse data acquired under additional data acquisition conditions. Other improvements include a customisable graphical user interface (GUI). Most diagnostic problems included have been addressed through a pattern-recognition based approach, in which classifiers based on linear discriminant analysis (LDA) were trained and tested. Conclusions: The INTERPRET DSS 3.0 allows radiologists, medical physicists, biochemists or, generally speaking, any person with a minimum knowledge of what an MR spectrum is, to enter their own SV raw data, acquired at 1.5 T, and to analyse them. The system is expected to help in the categorisation of MR Spectra from abnormal brain masses.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid21114820
dc.identifier.urihttps://hdl.handle.net/2445/126788
dc.language.isoeng
dc.publisherBiomed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/1471-2105-11-581
dc.relation.ispartofBMC Bioinformatics, 2010, vol. 11, num. 581
dc.relation.urihttps://doi.org/10.1186/1471-2105-11-581
dc.rightscc by (c) Pérez Ruiz et al., 2010
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationEspectroscòpia
dc.subject.classificationRessonància magnètica
dc.subject.classificationTumors cerebrals
dc.subject.otherSpectrum analysis
dc.subject.otherMagnetic resonance
dc.subject.otherBrain tumors
dc.titleThe INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Perez-RuizA.pdf
Mida:
3.31 MB
Format:
Adobe Portable Document Format